Filter
1594
Featured
144
516
Language
Document type
1086
226
129
55
40
20
15
11
8
3
1
Countries
91
64
50
46
45
44
43
43
41
41
38
36
32
29
28
28
27
26
25
25
25
23
23
23
22
22
16
13
12
12
12
12
10
9
7
7
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
777
114
68
47
27
21
7
2
Toolboxes
291
208
86
47
29
28
25
23
20
20
17
17
17
16
15
13
11
9
6
5
4
2
2
1
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management syste
...
Regional Action Plan for HIV in South-East Asia (2017-2021)
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance
...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
A Learning Programme for Professionals
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and
...
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diag
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines
...
